Nonstimulant Therapy for ADHD
The results of a multicenter, open-label, dose-titration study of GW320659, a novel norepinephrine and dopamine reuptake inhibitor, are reported from GlaxoSmithKline, Research Triangle Park, NC.
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Pediatric Neurology Briefs Publishers
2002-08-01
|
| Rangatū: | Pediatric Neurology Briefs |
| Ngā marau: | |
| Urunga tuihono: | https://www.pediatricneurologybriefs.com/articles/1601 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|